BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdelsameea E, Alsebaey A, Abdel-Samiee M, Abdel-Razek W, Salama M, Waked I. Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients. Expert Rev Anti Infect Ther 2021;19:1053-9. [PMID: 33307880 DOI: 10.1080/14787210.2021.1864326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Rewisha E, Salman T, Alhaddad O, Raia GA, Naguib M, Rashad S, Abdelfattah A, Metwally K, Abdelsameea E. Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients. Clin Exp Hepatol 2021;7:320-7. [PMID: 34712835 DOI: 10.5114/ceh.2021.109293] [Reference Citation Analysis]
2 Teima AAA, Amer AA, Mohammed LI, Kasemy ZA, Aloshari SH, Ahmed MM, Abuamer A, Shabaan A, Elzohry HA, Abdelwahab SF, Abdallah HM, Abdelmageed SM, Sakr MA, Abdel-Samiee M. A cross-sectional study of gastrointestinal manifestations in COVID-19 Egyptian patients. Ann Med Surg (Lond) 2022;:103234. [PMID: 35035951 DOI: 10.1016/j.amsu.2021.103234] [Reference Citation Analysis]
3 Ehsan N, Sweed D, Elsabaawy M. Evaluation of HCV-related liver fibrosis post-successful DAA therapy. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00129-0] [Reference Citation Analysis]